BlueCrest Capital Management’s Zimmer Biomet ZBH Stock Holding History

BlueCrest Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,800	Closed	-$233K	–	350
2023 Q1	$233K	Buy	+1,800	New	+$226K	0.01%	238
2018 Q3	–	Sell	-2,237	Closed	-$242K	–	1851
2018 Q2	$242K	Sell	2,237 -30,695	-93%	-$3.34M	0.01%	1225
2018 Q1	$3.49M	Sell	32,932 -77,221	-70%	-$8.97M	0.11%	202
2017 Q4	$12.9M	Buy	110,153 +13,856	+14%	+$1.57M	0.35%	54
2017 Q3	$10.9M	Buy	+96,297	New	+$11.1M	0.44%	52
2017 Q1	–	Sell	-10,197	Closed	-$1.02M	–	983
2016 Q4	$1.02M	Buy	10,197 +6,184	+154%	+$663K	0.06%	368
2016 Q3	$507K	Buy	+4,013	New	+$496K	0.02%	521
2016 Q2	–	Sell	-9,987	Closed	-$1.03M	–	1080
2016 Q1	$1.03M	Buy	9,987 +3,133	+46%	+$303K	0.06%	368
2015 Q4	$683K	Buy	+6,854	New	+$671K	0.03%	502

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BlueCrest Capital Management's ZBH Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 1,800 shares — an estimated $233K sold.

BlueCrest Capital Management first reported a position in ZBH in Q4 2015 and held it in 9 quarters. The position peaked at $12.9M in Q4 2017. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

BlueCrest Capital Management reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
BlueCrest Capital Management sold 1,800 Zimmer Biomet shares in Q2 2023, an estimated $233K.
BlueCrest Capital Management first reported a position in Zimmer Biomet in Q4 2015 and held it in 9 quarters.
BlueCrest Capital Management's Zimmer Biomet position peaked at $12.9M in Q4 2017.
1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.